Skip to main content

Advertisement

SpringerLink
Log in

Neurophysiology of cancer pain: From the laboratory to the clinic

  • Published:
Current Review of Pain Aims and scope Submit manuscript

Abstract

Pain is one of the most distressing symptoms associated with cancer. Basic science research has provided much insight into the mechanisms of peripheral and central pain and the actions of new drugs. Despite these advances, pain accompanying malignancy can be difficult to treat. Pain most commonly presents when the tumor has invaded somatic,visceral, or neural structures. An understanding of pain mechanisms is essential when deciding on the appropriate treatment. New therapeutic options have been developed and will hopefully provide clinicians with tools to successfully alleviate cancer pain.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References and Recommended Reading

  1. Bonica JJ: Importance of the problem. In Advances in Pain Research and Therapy, vol 2. Edited by Bonica JJ, et al. New York: Raven Press; 1979:1–12.

    Google Scholar 

  2. Foley KM: Pain syndromes in patients with cancer. In Advances in Pain Research and Therapy, vol 2. Edited by Bonica JJ et al. New York: Raven Press; 1979:59–75.

    Google Scholar 

  3. Portenoy RK: Cancer pain: epidemiology and syndromes. Cancer 1989, 63:2298–2307.

    CAS  PubMed  Google Scholar 

  4. Twycross R: Cancer pain classification. Acta Anaesthesiol Scand 1997, 41:41–145.

    Google Scholar 

  5. Cohen RS, Ferrer-Brechner T, Pavlov A, Reading AE: Prospective evaluation of treatment outcome in patients referred to a cancer pain center. Clin J Pain 1985, 1:105–109.

    Google Scholar 

  6. Kanner RM, Foley KM: Patterns of narcotic drug use in a cancer pain clinic. Ann N Y Acad Sci 1981, 362:161–172.

    CAS  PubMed  Google Scholar 

  7. Foley KM: The treatment of cancer pain. N Engl J Med 1985, 313:84–95.

    CAS  PubMed  Google Scholar 

  8. Portenoy RK: Cancer pain: pathophysiology and syndromes. Lancet 1992, 339:1026–1031.

    CAS  PubMed  Google Scholar 

  9. Koeller JM: Understanding cancer pain. Am J Hosp Pharm 1990, 47:S3-S6.

    CAS  PubMed  Google Scholar 

  10. Janig W: Neurophysiological mechanisms of cancer pain. Recent Results. Cancer Res 1984, 89:45–58.

    CAS  Google Scholar 

  11. Payne R: Anatomy, physiology and neuropharmacology of cancer pain. Med Clin North Am 1987, 71:153–168.

    CAS  PubMed  Google Scholar 

  12. Wall PD: Cancer pain: neurogenic mechanisms. In Advances in Pain Research and Therapy, vol 9. Proceedings of the Fourth World Congress in Pain. Edited by Fields HL, Dubner R, Cervero F. New York: Raven Press; 1985:575–587.

    Google Scholar 

  13. Willis WD: The Pain System. The Neural Basis of Nociceptive Transmission in the Mammalian Nervous System. Basel: Karger; 1985.

    Google Scholar 

  14. Fitzgerald M, Lynn B: The sensitization of high threshold mechanoreceptors with myelinated axons by repeated heating. J Physiol 1977, 265:549–563.

    PubMed Central  CAS  PubMed  Google Scholar 

  15. Schiable HG, Schmidt RF: Activation of groups III and IV sensory units in medial articular nerve by local mechanical stimulation of knee joint. J Neurophysiol 1983, 49:35–44.

    Google Scholar 

  16. Schiable HG, Schmidt RF: Effects of an experimental arthritis on the sensory properties of fine articular afferent units. J Neurophysiol 1985, 54:1109–1122.

    Google Scholar 

  17. Habler HJ, Janig W, Koltzenburg M: Activation of unmyelinated afferent fibres by mechanical stimuli and inflammation of the urinary bladder in the cat. J Physiol 1990, 425:545- 562.

    PubMed Central  CAS  PubMed  Google Scholar 

  18. Handwerker HO, Kilo S, Reeh PW: Unresponsive afferent nerve fibres in the sural nerve of the rat. J Physiol 1991, 435:229–242.

    PubMed Central  CAS  PubMed  Google Scholar 

  19. Davis KD, Meyer RA, Campbell JN: Chemosensitivity and sensitization of nociceptive afferents that innervate the hairy skin of monkey. J Neurophysiol 1993, 69:1071–1081.

    CAS  PubMed  Google Scholar 

  20. Schmidt RF, Schiable H-G, Messlinger K, et al.: Silent and active nociceptors: structure, functions, and clinical implications. In Progress in Pain Research and Management, vol 2. Proceedings of the 7th World Congress on Pain. Edited by Gebhart GF, Hammond DL, Jensen TS. Seattle: IASP Press; 1994:213–250.

    Google Scholar 

  21. Willis WD, Westlund KN: Neuroanatomy of the pain system and of the pathways that modulate pain. J Clin Neurophysiol 1997, 141:2–31. This paper gives a detailed account of the neuroanatomy and mechanisms of pain transmission, with particular emphasis on relevant clinical applications.

    Google Scholar 

  22. Willis WD, Coggeshall RE: Sensory Mechanisms of the Spinal Cord, edn 2. New York: Plenum Press; 1991.

    Google Scholar 

  23. Goodman SJ, Holcombe V: Selective and prolonged analgesia in monkey resulting from brain stimulation. In Advances in Pain Research and Therapy, vol 1. Edited by Bonica JJ, Albe-Fessard D. New York: Raven Press; 1976:495–502.

    Google Scholar 

  24. Hosobuschi Y, Adams JE, Rutkin B: Chronic thalamic stimulation for the control of facial anaesthesia dolorosa. Arch Neurol 1973, 29:158–161.

    Google Scholar 

  25. Turnbull IM, Shulman R, Woodhurst AWB: Thalamic stimulation for neuropathic pain. J Neurosurgery 1980, 52:486–493.

    CAS  Google Scholar 

  26. Kenshalo DR, Willis WD: The role of the cerebral cortex in pain sensation. In Cerebral Cortex: Normal and Altered States of Function, vol 9. Edited by Peters A, Jones EG. New York: Plenum Press; 1991:153–212.

    Google Scholar 

  27. Coghill RC, Talbot JD, Evans AC, et al.: Distributed processing of pain and vibration by the human brain. J Neurosci 1994, 14:4095–4108.

    CAS  PubMed  Google Scholar 

  28. Jensen TS: Opioids in the brain: supraspinal mechanisms in pain control. Acta Anaesthesiol Scand 1997, 41:123–132. This paper reviews the current knowledge of the role of opioids in supraspinal pain mechanisms. It details recent animal and human data on opioid receptor systems and the therapeutic implications.

    CAS  PubMed  Google Scholar 

  29. Sandouk P, Serrie A, Urtizberea M, et al.: Morphine pharmacokinetics and pain assessment after intracerebroventricular administration in patients with terminal cancer. Clin Pharmacol Ther 49:442–448.

  30. Lenzi A, Gallai G, Gandolfini M, Marini G: Intraventricular morphine in paraneoplastic painful syndrome of the cervicofacial region: experience in thirty-eight cases. Neurosurgery 1985, 17(1):6–11.

    CAS  PubMed  Google Scholar 

  31. Fields HL, Basbaum A: Central nervous system mechanisms of pain modulation. In Textbook of Pain. Edited by Wall PD, Melzack R. Edinburgh: Churchill Livingstone; 1994:243–257.

    Google Scholar 

  32. Khan ZP, Ferguson CN, Jones RM: Alpha2 and imidazole receptor agonists. Anaesthesia 1999, 54:146–165.

    CAS  PubMed  Google Scholar 

  33. Howe JR, Wan J-Y, Yasch TL: Selective antagonism of the antinociceptive effect of intrathecally applied alpha-adrenergic agonists by intrathecal prazocin and intrathecal yohimbine. J Pharmacol Exp Ther 1983, 224:552–558.

    CAS  PubMed  Google Scholar 

  34. Kuraishi Y, Hirota N, Sato Y, et al.: Noradrenergic inhibition of the release of substance P from primary afferents in rabbits spinal dorsal horn. Brain Res 1985, 359:177–182.

    CAS  PubMed  Google Scholar 

  35. Klimscha W, Tong C, Eisenach JC: Intrathecal a2-adrenergic agonists stimulate acetylcholine and norepinephrine release from the spinal cord dorsal horn in sheep. An in vivo microdialysis study. Anesthesiology 1997, 87:110–116.

    CAS  PubMed  Google Scholar 

  36. Lee Y-W, Yasch TL: Analysis of drug interaction between intrathecal clonidine and MK-801 in peripheral neuropathic pain rat model. Anesthesiology 1995, 82:741–748.

    CAS  PubMed  Google Scholar 

  37. Eisenach JC, Rauck RL, Buzzanell C, Lysak SZ: Epidural clonodine analgesia for intractable cancer pain: phase I. Anesthesiology 1989, 71:647–652.

    CAS  PubMed  Google Scholar 

  38. Eisenach JC, DuPen S, Dubois N, et al.: Epidural clonidine analgesia for intractable cancer pain. Pain 1995, 61:391–399.

    CAS  PubMed  Google Scholar 

  39. Stamford JA: Descending control of pain. Br J Anaesth 1995, 75:217–227.

    CAS  PubMed  Google Scholar 

  40. Go VL, Yasch TL: Release of substance P from the cat spinal cord. J Physiol 1987, 391:141–167.

    PubMed Central  CAS  PubMed  Google Scholar 

  41. Duggan AW, Hendry IA, Morton CR, et al.: Cutaneous stimuli releasing immunoreactive substance P in the dorsal horn of the cat. Brain Res 1988, 451:261–273.

    CAS  PubMed  Google Scholar 

  42. Dray A: Tasting the inflammatory soup: role of peripheral neurons. Pain Rev 1994, 1:153–171.

    Google Scholar 

  43. Saria A: Substance P in sensory nerve fibers contributes to the development of oedema in the rat hindpaw after thermal injury. Br J Pharmacol 1984, 323:341–342.

    Google Scholar 

  44. Helme RD, Andrews PV: The effect of nerve lesions on the inflammatory response to injury. J Neurosci Res 1985, 13:453- 459.

    CAS  PubMed  Google Scholar 

  45. Saito A, Kimura S, Goto K: Calcitonin gene-related peptide as potential neurotransmitter in guinea-pig right atrium. Am J Physiol 1986, 250:H693-H698.

    CAS  PubMed  Google Scholar 

  46. Payan DG, Levine JD, Goetzl EJ: Modulation of immunity and hypersensitivity by sensory neuropeptides. J Immunol 1984, 132:1601–1604.

    CAS  PubMed  Google Scholar 

  47. Hartung H-P, Wolters K, Tokya KV: Substance P binding properties and studies on cellular responses in guinea-pig macrophages. J Immunol 1986, 136:3856–3863.

    CAS  PubMed  Google Scholar 

  48. Johnson AR, Erdos EG: Release of histamine from mast cells by vasoactive peptides. Proc Soc Exp Biol Med 1973, 142:1252- 1256.

    CAS  PubMed  Google Scholar 

  49. Schiable H-G, Schmidt RF: Time course and mechanosensitivity changes in articular afferents during a developing experimental arthritis. J Neurophysiol 1988, 60:2180–2195.

    Google Scholar 

  50. Birch PJ, Harrison SM, Hayes AG, et al.: The non-peptide NK1 receptor antagonist,(±)-CP-96,345, produces antinociception and anti-oedema effects in the rat. Br J Pharmacol 1992, 105:508–510.

    PubMed Central  CAS  PubMed  Google Scholar 

  51. Rang HP, Bevan S, Dray A: Nociceptive peripheral neurones: cellular properties. In Textbook of Pain. Edited by Wall PD, Melzack R. Edinburgh: Churchill Livingstone; 1994:57–78.

    Google Scholar 

  52. Raja SN, Kozak SL, Manning DC, et al.: Intradermal bradykinin induces hyperalgesia to heat stimuli in man. Pain 1990, 5(suppl):S130.

    Google Scholar 

  53. Kumazawa T, Mizumura K, Minagawa M, Tsujii Y: Sensitizing effects of bradykinin on the heat responses of the visceral nociceptor. J Neurophysiol 1991, 66(6):1819–1824.

    CAS  PubMed  Google Scholar 

  54. Levine JD, Taiwo YO, Collins S, Tam J: Noradrenaline hyperalgesia is mediated through interaction with sympathetic postganglionic neurone terminals rather than activation of primary afferent nociceptors. Nature 1986, 323:158–159.

    CAS  PubMed  Google Scholar 

  55. Taiwo YO, Levine JD: Characterisation of the arachadonic acid metabolites mediating bradykinin and noradrenaline hyperalgesia. Brain Res 1988, 458:402–406.

    CAS  PubMed  Google Scholar 

  56. Melmon KL, Webster ME, Goldfiner SE, Seegmiller JE: The presence of a kinin in inflammatory synovial effusion from arthritides of varying etiologies. Arthritis Rheum 1967, 10:13- 20.

    CAS  PubMed  Google Scholar 

  57. Rocha E, Silver M, Rosenthal SR: Release of pharmacologically active substances from the rat skin in vivo following thermal injury. J Pharmacol Exp Ther 1961, 132:110–116.

    Google Scholar 

  58. Ferreria SH, Lorenzetti BB, Bristow AF, Poole S: Interleukin-1b as a potent hyperalgesic agent antagonized by a tripeptide analogue. Nature 1988, 334:698–700.

    Google Scholar 

  59. Cunha FQ, Poole S, Lorenzetti BB, Ferreira SH: The pivotal role of tumour necrosis factor a in the development of inflammatory hyperalgesia. Br J Pharmacol 1992, 107:660–664.

    PubMed Central  CAS  PubMed  Google Scholar 

  60. Davis AJ, Perkins MN: The involvement of bradykinin B1 and B2 receptor mechanisms in cytokine-induced mechanical hyperalgesia in the rat. Br J Pharmacol 1994, 113:63–68.

    PubMed Central  CAS  PubMed  Google Scholar 

  61. Jonakait GM: Neural-immune interactions in sympathetic ganglia. Trends Neurosci 1993, 10:419–423.

    Google Scholar 

  62. Levine JD, Gooding J, Donatoni B, et al.: The role of the polymorphonuclear leukocyte in hyperalgesia. J Neurosci 1985, 5:3025–3029.

    CAS  PubMed  Google Scholar 

  63. Levine JD, Fields HL, Basbaum AI: Peptides and the primary afferent nociceptor. J Neurosci 1993, 13:2273–2286.

    CAS  PubMed  Google Scholar 

  64. DiStephano PS, Friedman B, Radziejewski C, et al.: The neurotrophins BDNF, NT-3, and NGF display distinct patterns of retrograde axonal transport in peripheral neurons. Neuron 1992, 8:983–993.

    Google Scholar 

  65. Lewin G, Mendell LM: Nerve growth factor and nociception. Trends Neurosci 1993, 16:353–359.

    CAS  PubMed  Google Scholar 

  66. Donnerer J, Schuligoi R, Stein C: Increased content and transport of substance P and CRGP in sensory nerves innervating inflamed tissue: evidence for regulatory function of nerve growth factor in vivo. Neuroscience 1992, 49:693–698.

    CAS  PubMed  Google Scholar 

  67. Lindsay RM, Harmar AJ: Nerve growth factor regulates expression in neuropeptide genes in adult sensory neurons. Nature 1989, 337:362–364.

    CAS  PubMed  Google Scholar 

  68. Petty BG, Cornblath DR, Adornato BT, et al.: The effect of systemically administered recombinant human nerve growth factor in healthy human subjects. Ann Neurol 1994, 36:244- 246.

    CAS  PubMed  Google Scholar 

  69. Anand P, Rudge P, Mathias CJ, et al.: A new autonomic and sensory neuropathy with loss of adrenergic sympathetic function and sensory neuropeptides. Lancet 1991, 337:1353- 1355.

    Google Scholar 

  70. Yasch TL, Malmberg AB: Central pharmacology of nociceptive transmission. In Textbook of Pain. Edited by Wall PD, Melzack R. Edinburgh: Churchill Livingstone; 1994:165–200.

    Google Scholar 

  71. Headley PM, Grillner S: Excitatory amino-acids and synaptic transmission: the evidence for a physiological function. Trends Pharmacol Sci 1990, 11:205–211.

    CAS  PubMed  Google Scholar 

  72. Dickenson AH: NMDA-receptor antagonists: interactions with opioids. Acta Anaesth Scand 1997, 4(1):112–115.

    Google Scholar 

  73. Neugebauer V, Rumenapp P, Schiable H-G: Calcitonin generelated peptide is involved in the spinal processing of mechanosensory input from the rat’s knee joint and in the generation and maintenance of hyperexcitability of dorsal horn neurons during the development of acute inflammation. Neuroscience 1996, 71:1095–1109.

    CAS  PubMed  Google Scholar 

  74. Schiable H-G, Jarrot B, Hope PJ, Duggan AW: Release of immunoreactive substance P in cat spinal cord during development of acute arthritis in the cat’s knee: a study with antibody bearing microprobes. Brain Res 1990, 529:214–223.

    Google Scholar 

  75. Sorkin LS, Westlund KN, Sluka KA, et al.: Neural changes in acute arthritis in monkeys.IV. Time-course of amino-acid release into the dorsal horn. Brain Res Rev 1992, 17:39–50.

    CAS  PubMed  Google Scholar 

  76. Yammamoto T, Yasch TL: Spinal pharmacology of thermal hyperesthesia induced by constriction injury of sciatic nerve. Excitatory amino acid antagonists. Pain 1992, 49:121–128.

    Google Scholar 

  77. Coderre TJ, Katz J, Vaccarino AL, Melzack R: Contribution of central neuroplasticity to pathological pain: review of clinical and experimental evidence. Pain 1993, 53:259–285.

    Google Scholar 

  78. Eide PK, Jorum E, Stubhaug A, et al.: Relief of post-herpetic neuralgia with the N-methyl-D-aspartate receptor antagonist ketamine. Pain 1994, 58:347–354.

    CAS  PubMed  Google Scholar 

  79. Price DD, Mao J, Mayer DJ: Central neural mechanisms of normal and abnormal pain states. In Progress in Pain Research and Management. Edited by Fields HL, Lebeskind JC. Seattle: IASP Press; 1994:61–84.

    Google Scholar 

  80. Handwerker HO, Reeh PW: Pain and inflammation. In Proceedings of the VIth World Congress on Pain. Edited by Bond MR,Charlton JE, Wolf CE. Amsterdam: Elsevier; 1991:59–70.

    Google Scholar 

  81. Treede R-D, Meyer RA, Raja SN, Campbell JN: Peripheral and central mechanisms of cutaneous hyperalgesia. Prog Neurobiol 1992, 38:397–421.

    CAS  PubMed  Google Scholar 

  82. Raja SN, Meyer RA, Campbell JN: Peripheral mechanisms of somatic pain. Anesthesiology 1988, 68:571–590.

    CAS  PubMed  Google Scholar 

  83. Dray A, Perkins MN: Bradykinin and inflammatory pain. Trends Neurol Sci 1993, 12:3025–3041.

    Google Scholar 

  84. Dray A, Urban L, Dickenson AH: Pharmacology of chronic pain. Trends Pharmacol Sci 1994, 15:190–197.

    CAS  PubMed  Google Scholar 

  85. Thompson SWN, King AE, Woolf CJ: Activity-dependent changes in rat ventral horn neurons in vitro; summation of prolonged afferent evoked post-synaptic depolarizations produce a d-APV sensitive windup. Eur J Neurosci 1990, 2:638–349.

    CAS  PubMed  Google Scholar 

  86. Nagi I, Maggi CA, Dray A, et al.: The role of neurokinin and Nmethyl- D-aspartate receptors in synaptic transmission from capsaicin sensitive primary afferents in the rat spinal cord in vitro. Neuroscience 1993, 52:1029–1037.

    Google Scholar 

  87. Chen L, Huang L-YM: Protein kinase C reduces Mg2+ block of NMDA-receptor channels as a mechanism of modulation. Nature 1992, 356:521–523.

    CAS  PubMed  Google Scholar 

  88. Hunt SP, Pini A, Evan G: Induction of c-fos-like protein in spinal cord neurons following sensory stimulation. Nature 1987, 328:632–634.

    CAS  PubMed  Google Scholar 

  89. Munglani R, Hunt SP: Molecular biology of pain. Br J Anaesth 1995, 75:186–192.

    CAS  PubMed  Google Scholar 

  90. Presley RW, Menetrey D, Levine JD, Basbaum AI: Systemic morphine suppresses noxious stimulus-evoked fos protein-like immunoreactivity in the rat spinal cord. J Neuroscience 1990, 10:323–335.

    CAS  Google Scholar 

  91. Munglani R, Fleming BG, Hunt SP: Remembrance of times past: the significance of c-fos in pain. Br J Anaesth 1996, 76(1):1–3.

    CAS  PubMed  Google Scholar 

  92. Coderre TJ, Grimes RW, Melzack R: Deafferentation and chronic pain in animals: an evaluation of evidence suggesting autotomy is related to pain. Pain 1986, 26:61–84.

    CAS  PubMed  Google Scholar 

  93. Niedbala B, Sanchez A, Feria M: Nitric oxide mediates neuropathic pain behavior in peripherally denervated rats. Neurosci Lett 1995, 188(1):57–60.

    CAS  PubMed  Google Scholar 

  94. Brescia FJ, Adler D, Gray G, et al.: Hospitalized advanced cancer patients: a profile. J Pain Symptom Manage 1990, 5:221- 227.

    CAS  PubMed  Google Scholar 

  95. Twycross RG, Fairfield S: Pain in far-advanced cancer. Pain 1982, 14:303–310.

    CAS  PubMed  Google Scholar 

  96. Bjurholm A, Kreicbergs A, Brodin E., Schultzberg M: Substance P and CCRP-immunoreactive nerves in bone. Peptides 1988, 9:165–171.

    CAS  PubMed  Google Scholar 

  97. Campa JA, Payne R: The management of intractable bone pain: a clinician’s perspective. Semin Nucl Med 1992, 22:3–10.

    PubMed  Google Scholar 

  98. Foley KM: Pain assessment and cancer pain syndromes. In Oxford Textbook of Palliative Medicine. Edited by Doyle D, Hanks GW, Mc Donald N. Oxford: Oxford Medical Publications; 1993:148–165.

    Google Scholar 

  99. Mundy GR: Bone resorption and turnover in health and disease. Bone 1987, 8:S9-S16.

    PubMed  Google Scholar 

  100. Fulfaro F, Casuccio A, Ticozzi C, Ripamonti C: The role of bisphosphonates in the treatment of painful metastatic bone disease: a review of phase III trials. Pain 1998, 78:157–169.

    CAS  PubMed  Google Scholar 

  101. Blatch GL, Zetter BR: Bone marrow-derived growth factors for metastatic cancer cells. In Bone Metastasis-Mechanisms and Pathophysiology. Edited by Orr FW, Singh G. New York: Chapman and Hall; 1996.

    Google Scholar 

  102. Galasko CSB: Mechanisms of bone destruction in the development of skeletal metastases. Nature 1986, 263:507–508.

    Google Scholar 

  103. Arguello F, Baggs RB, Graves BT, et al.: Effect of IL-1 on experimental bone/bone marrow metastases. Int J Cancer 1992, 52:802–807.

    CAS  PubMed  Google Scholar 

  104. Adami S: Bisphosphonates in prostate carcinoma. Cancer 1997, 80:1674–1679.

    CAS  PubMed  Google Scholar 

  105. Ohya K, Yamada S, Felix R, Fleisch H: Effect of bisphosphonates on prostaglandin synthesis by rat bone cells and mouse calvaria in culture. Clin Sci 1985, 69(4):403–411.

    CAS  PubMed  Google Scholar 

  106. Hortobagyi GN, Theriault RL, Porter L, et al.: Efficacy of pamidronate in reducing skeletal complications in patients with breast cancer and lytic bone metastases. N Engl J Med 1996, 335:1785–1791.

    CAS  PubMed  Google Scholar 

  107. Berenson JR, Lichtenstein A, Porter L, et al.: Efficacy of pamidronate in reducing skeletal complications in patients with advanced multiple myeloma. N Engl J Med 1996, 334:488- 493.

    CAS  PubMed  Google Scholar 

  108. Lipton A, Hershey PA, Theriault R, et al.: Long-term reduction of skeletal complications in breast cancer patients with osteolytic bone metastases receiving hormone therapy, by monthly 90mg pamidronate infusions [abstract]. Proc Am Soc Clin Oncol 1997, 16:152–153.

    Google Scholar 

  109. Mc Cormack K: Non-steroidal anti-inflammatory drugs and spinal nociceptive processing. Pain 1994, 59:9–43.

    Google Scholar 

  110. Tannock I, Gospodarowicz M, Meakin W, et al.: Treatment of metastatic prostatic cancer with low dose prednisone: evaluation of pain and quality of life as pragmatic indices of response. J Clin Oncol 1989, 7:590–597.

    CAS  PubMed  Google Scholar 

  111. Mac Donald N: Principles governing the use of cancer chemotherapy in palliative medicine. In Oxford Textbook of Palliative Medicine. Edited by Doyle D, Hanks GW, MacDonald N. Oxford: Oxford Medical Publications; 1993:105–117.

    Google Scholar 

  112. Collin E, Poulain P, Gauvain-Piquard A, et al.: Is disease progression the major factor in morphine “tolerance” in cancer pain treatment? Pain 1993, 55:319–326.

    CAS  PubMed  Google Scholar 

  113. Foley KM: Changing Concepts of Tolerance to Opioids Current and Emerging Issues in Cancer Pain: Research and Practice. Edited by Chapman C, Foley KM. New York: Raven Press; 1993:331–350.

    Google Scholar 

  114. Collin E, Cesselin F: Neurobiological mechanisms of opioid tolerance and dependence. Clin Neuropharmacol 1991, 14(6):465–488.

    CAS  PubMed  Google Scholar 

  115. Trujillo KA, Akil H: Inhibition of morphine tolerance and dependence by NMDA receptor antagonist MK-801. Science 1991, 251:85–87.

    CAS  PubMed  Google Scholar 

  116. Shimoyama N, Shimoyama M, Inturrisi CE, Elliott KJ: Ketamine attenuates and reverses morphine tolerance in rodents. Anesthesiology 1996, 85:1357–1366.

    CAS  PubMed  Google Scholar 

  117. Elliott K, Minami N, Kolesnikov YA, et al.: The NMDA receptor antagonists, LY274614 and MK-801, and the nitric oxide synthase inhibitor, NG-nitro-L-arginie, attenuate analgesic tolerance to the mu-opioid morphine but not to kappa opioids. Pain 1994, 56:69–75.

    CAS  PubMed  Google Scholar 

  118. Bilksy EJ, Inturrisi CE, Sadee W, et al.: Competitive and noncompetitive NMDA antagonists block the development of anti-nociceptive tolerance tp morphine, but not to selective mu or delta opioid agonists in mice. Pain 1996, 68:229–237.

    Google Scholar 

  119. Mao J, Price DD, Mayer DJ: Mechanisms of hyperalgesia and morphine tolerance: a current view of their possible interactions. Pain 1995, 62:259–274.

    CAS  PubMed  Google Scholar 

  120. Brodsky M, Elliott K, Hynansky A, et al.: NMDA receptor and proenkephalin gene expression are modulated by chronic morphine administered alone or in combination with NMDA antagonist [abstract]. Soc Neurosci 1993, 19:1352.

    Google Scholar 

  121. Goligher JC, Hughes ESR: Sensibility of the rectum and colon: its role in the mechanism of anal continence. Lancet 1951, 1- 2:543–548.

    Google Scholar 

  122. Habler H-J, Janig W, Koltzenberg M: Activation of unmyelinated afferent fibers by mechanical stimuli and inflammation of the urinary bladder in the cat. J Physiol (Lond) 1990, 425:545–562.

    CAS  Google Scholar 

  123. Ness TJ, Gebhart GF: Visceral pain: a review of experimental studies. Pain 1990, 41:167–234.

    CAS  PubMed  Google Scholar 

  124. Ness TJ, Randich A, Gebhart GF: Further behavioural evidence that colorectal distension is a noxious visceral stimulus in rats. Neurosci Lett 1991, 131:113–116.

    CAS  PubMed  Google Scholar 

  125. Cervero F: Pathophysiology of referred pain and hyperalgesia from viscera. In New Trends in Referred Pain and Hyperalgesia, Pain Research and Clinical Management, vol 7. Edited by Vecchiet L, Albe-fessard D,Lindblom U, et al. Amsterdam: Elsevier Science; 1993:35–46.

    Google Scholar 

  126. Birder L, DeGroat W: Increased c-fos expression in spinal neurones after irritation of the lower urinary tract in the rat. J Neurosci 1992a, 12:4878–4889.

    CAS  PubMed  Google Scholar 

  127. Birder L, DeGroat W: The effect of glutamate antagonists on cfos expression induced in spinal neurones by irritation of the lower urinary tract. Brain Res 1992b, 580:115–120.

    CAS  Google Scholar 

  128. Rice A, McMahon S: Pre-emptive intrathecal administration of an NMDA receptor antagonist (AP 5) prevents hyper-reflexia in a model of persistent visceral pain. Pain 1994, 57:335–340.

    CAS  PubMed  Google Scholar 

  129. McMahon SB: Neuronal and behavioural consequences of chemical inflammation of rat urinary bladder. Agents Actions 1988, 25(3,4):231–233.

    CAS  PubMed  Google Scholar 

  130. Lema MJ, Myers DP, deLeon-Casasola OA, Penetrante R: Pleural phenol therapy for treatment of chronic oesophageal pain. Reg Anesth 1992, 17:166–170.

    CAS  PubMed  Google Scholar 

  131. Al-Chaer ED, Lawand ND, Westlund KN, Willis WD: Visceral nociceptive input into the ventral posterolateral nucleus of thalamus: a new function for the dorsal column pathway. J Neurophysiol 1996, 76:2661–2674.

    CAS  PubMed  Google Scholar 

  132. Al-Chaer ED, Lawand ND, Wesrlund KN, Willis WD: Pelvic visceral input into the nucleus gracilis is largely mediated by the postsynaptic dorsal column pathway. J Neurophysiol 1996, 76:2675–2690.

    CAS  PubMed  Google Scholar 

  133. Hirshberg RM, Al-Chaer ED, Lawand ND, et al.: Is there a pathway in the dorsal funiculus that signals visceral pain? Pain 1996, 67:291–305.

    PubMed Central  CAS  PubMed  Google Scholar 

  134. Al-Chaer ED, Feng Y, Willis WD: A role for the dorsal column in nociceptive visceral input into the thalamus of primates. J Neurophysiol 1998, 79:143–150.

    Google Scholar 

  135. Gildenberg P, Hirshberg R: Limited myelotomy for the treatment of intractable cancer pain. J Neurol Neurosurg Psychiatry 1984, 47(1):94–96.

    PubMed Central  CAS  PubMed  Google Scholar 

  136. Nauta HJW, Hewitt E, Westlund KN, Willis WD: Surgical interruption of a midline dorsal column visceral pain pathway. J Neurosurg 1997, 86:538–542.

    CAS  PubMed  Google Scholar 

  137. Feng W, Cui M, Al-Chaer ED, Willis WD: Epigastric antinociception by cervical dorsal column lesions in rats. Anesthesiology 1998, 89:411–420.

    CAS  PubMed  Google Scholar 

  138. Gilbert RW, Klin JH, Posner JB: Epidural spinal cord compression from metastatic tumour. Ann Neurol 1978, 5:40–51.

    Google Scholar 

  139. Chung K, Kim HJ, Na HS, et al.: Abnormalities of sympathetic innervation in the area of an injured peripheral nerve in a rat model of neuropathic pain. Neurosci Lett 1993, 162:85–88.

    CAS  PubMed  Google Scholar 

  140. Devor M: Neuropathic pain and injured nerve: peripheral mechanisms. Br Med Bull 1991, 47:619–630.

    CAS  PubMed  Google Scholar 

  141. Sotgiu ML, Lacerenza M, Marchettini P: Effect of systemic lidocaine on dorsal horn neuron hyperactivity following chronic peripheral nerve injury in rats. Somatosens Mot Res 1992, 9(3):227–233.

    CAS  PubMed  Google Scholar 

  142. Wall PD, Devor M: Sensory afferent impulses originate from dorsal root ganglia as well as from the periphery in normal and injured rats. Pain 1983, 17(4):321–339.

    CAS  PubMed  Google Scholar 

  143. Yaksh TL, Chaplan SR: Physiology and pharmacology of neuropathic pain. Anesth Clin North Am 1997 15(2):335–352.

    CAS  Google Scholar 

  144. Portenoy RK: Management of neuropathic pain. In Current and Emerging Issues in Cancer Pain: Research and Practice. Edited by Chapman CR, Foley KM. New York: Raven Press Ltd.; 1993:351–369.

    Google Scholar 

  145. Dickenson AH: Neurophysiology of opioid poorly responsive pain. Cancer Surv 1994, 21:5–16.

    CAS  PubMed  Google Scholar 

  146. Arner S, Meyerson BA: Lack of analgesic effect of opioids on neuropathic and idiopathic forms of pain. Pain 1988, 33:11- 23.

    CAS  PubMed  Google Scholar 

  147. Besson JM, Besse D, Lombard MC, et al.: Opioids and neuropathic pain: experimental approaches in the rat. In Current and Emerging Issues in Cancer Pain: Research and Practice. Edited by Chapman CR, Foley KM. New York: Raven Press Ltd.; 1993:129–152.

    Google Scholar 

  148. Dickenson AH: Spinal cord pharmacology. Br J Anaesth 1995, 75:193–200.

    CAS  PubMed  Google Scholar 

  149. Sadove MS, Shulman M, Hatano S, et al.: Analgesic effects of ketamine administered in subdissociative doses. Anesth Analg 1971, 50:452–457.

    CAS  PubMed  Google Scholar 

  150. Mercadante S: Ketamine in cancer pain: an update. Palliat Med 1996, 10(3):225–230.

    CAS  PubMed  Google Scholar 

  151. Pud D, Eisenberg E, Spitzer A, et al.: The NMDA receptor antagonist amantadine reduces surgical neuropathic pain in cancer patients: a double blind, randomized, placebo controlled trial. Pain 1998, 75:349–354.

    CAS  PubMed  Google Scholar 

  152. Spiegel K, Kalb R, Pasternak GW: Analgesic activity of tricyclic antidepressants. Ann Neurol 1983, 13:462–465.

    CAS  PubMed  Google Scholar 

  153. Eisenach JC, Gebhart GF: Intrathecal amitrptyline acts as an N-Methyl-D-Aspartate receptor antagonist in the presence of inflammatory hyperalgesia in rats. Anesthesiology 1995, 83:1046–1054.

    CAS  PubMed  Google Scholar 

  154. Weinberger J, Nicklas WJ, Berl S: Mechanism of action of anticonvulsants. Neurology 1976, 26:162–173.

    CAS  PubMed  Google Scholar 

  155. Pan H-L, Eisenach JC, Chen S-R: Gabapentin suppresses ectopic nerve discharges and reverses allodynia in neuropathic rats. J Pharmacol Exp Ther 1999, 288:1026–1030.

    CAS  PubMed  Google Scholar 

  156. Chapman V, Suzuki R, Chamarette HL, et al.: Effects of systemic carbamazepine and gabapentin on spinal neuronal responses in spinal nerve ligated rats. Pain 1998, 75:261–272.

    CAS  PubMed  Google Scholar 

  157. Dejgard A, Peterson P, Kastrup J: Mexiletine for treatment of chronic painful diabetic neuropathy. Lancet 1988, 1:9–11.

    CAS  PubMed  Google Scholar 

  158. Chabal C, Jacobson L, Mariano A, et al.: The use of oral mexiletine for the treatment of pain after peripheral nerve injury. Anesthesiology 1992, 76:513–517.

    CAS  PubMed  Google Scholar 

  159. Devor M, Wall PD, Catalan N: Systemic lidocaine silences ectopic neuroma and DRG discharge without blocking nerve conduction. Pain 1992, 48:261–268.

    CAS  PubMed  Google Scholar 

  160. Abdi S, Lee DH, Chung JM: The anti-allodynic effects of amitriptyline, gabapentin, and lidocaine in a rat model of neuropathic pain. Anesth Analg 1998, 87:1360–1366.

    CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Anesthesia and Pain Management, Toronto Western Hospital, 399 Bathurst Street, M5T 2S8, Toronto, Ontario, Canada

    Joan M. Regan MB & Philip Peng MB, FRCPC

Authors
  1. Joan M. Regan MB
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Philip Peng MB, FRCPC
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Vincent W. S. Chan MD, FRCPC
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Regan, J.M., Peng, P. & Chan, V.W.S. Neurophysiology of cancer pain: From the laboratory to the clinic. Current Review of Pain 3, 214–225 (1999). https://doi.org/10.1007/s11916-999-0016-y

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s11916-999-0016-y

Keywords

Search

Navigation